August 29, 2024 August 29, 2024Categories News StoriesHow the CompassHER2 pCR trial (EA1181) and other novel studies seek to optimize HER2+ breast cancer management
May 14, 2024 May 14, 2024Categories News StoriesmyeloMATCH, the next revolution in the NCI’s National Clinical Trials Network
May 14, 2024 May 14, 2024Categories News StoriesIncreasing inclusion and equity for Black women in breast cancer clinical trials (mentions EAZ171)
May 14, 2024 May 14, 2024Categories News StoriesNCCN recommends universal testing for MSI and dMMR for all newly diagnosed gastric cancer patients
May 8, 2024 May 8, 2024Categories Press ReleasesPress Release: ECOG-ACRIN adds another trial to the ComboMATCH precision oncology study platform
April 4, 2024 April 4, 2024Categories Announcements News StoriesThe Spring 2024 advocacy blog Considering Clinical Trials is now available
March 4, 2024 March 4, 2024Categories Press ReleasesPress Release: NCI-MATCH cancer trial discovers a potentially broader role for an established dual HER2-blocking treatment
February 16, 2024 February 16, 2024Categories News StoriesAACR’s Clinical Cancer Research publishes a review article, “Tumor-Specific Activity of Precision Medicines in the NCI-MATCH Trial”
